Failing to Protect: The Regulatory Industry’s Challenge in Curbing Nicotine Addiction Among Adolescents

Posted on April 16, 2024Mariam SalmanzadehCategories Food and Drug LawLeave a comment on Failing to Protect: The Regulatory Industry’s Challenge in Curbing Nicotine Addiction Among Adolescents

In the battle against nicotine addiction, particularly among our nation’s youth, the regulatory industry stands as a crucial line of defense. However, recent developments suggest that this block is faltering, leaving our young generation increasingly vulnerable to the grips of addiction. Despite well-intentioned efforts, the regulatory landscape surrounding nicotine products has proven inadequate in safeguarding young adults from the harmful effects of addiction. In this blog post, the shortcomings of current regulations and propose actionable solutions to address this pressing issue will be explored.

Like A “Good Neighbor”: EPA Waits For U.S. Supreme Court Ruling on Rule Regulating Air Emissions Under the Clean Air Act

Posted on April 11, 2024Sarah FritzCategories EnvironmentalLeave a comment on Like A “Good Neighbor”: EPA Waits For U.S. Supreme Court Ruling on Rule Regulating Air Emissions Under the Clean Air Act

On February 21, 2024, the Environmental Protection Agency (EPA) argued in front of the U.S. Supreme Court, attempting to continue regulation of the “Good Neighbor” rule in eleven states. The EPA announced the final “Good Neighbor Plan” on March 15, 2023. The “Good Neighbor Plan” established under the Clean Air Act (CAA) aims at reducing emissions from upwind states that cause pollution in downwind states.

Artificial Intelligence and Health Insurance Claim Denials

Posted on April 10, 2024Jason VelliganCategories UncategorizedLeave a comment on Artificial Intelligence and Health Insurance Claim Denials

Jason VelliganAssociate EditorLoyola University Chicago School of Law, JD 2024 Artificial intelligence headlines are grabbing the attention of people from most industries. Artificial intelligence helps doctors diagnose and treat patients, and pharmaceutical manufacturers develop new medications. Politicians, subject matter experts, and numerous publications voice concerns over using artificial intelligence. In late 2023, class actions were …
Read more
Tags

Government Agencies Unite to Regulate Corporate Greed in Healthcare Systems

Posted on April 9, 2024Amanda MeyerCategories UncategorizedLeave a comment on Government Agencies Unite to Regulate Corporate Greed in Healthcare Systems

The Federal Trade Commission, Department of Justice Antitrust Division and the Department of Health and Human Services are working together to gather information on healthcare transactions, including various nonreportable deals and anticompetitive practices that harm patient’s health, safety, quality of care and affordability.

Fifth Circuit Grants Administrative Stay for SEC Climate Disclosure Rule

Posted on April 8, 2024Amanda LaneCategories EnvironmentalLeave a comment on Fifth Circuit Grants Administrative Stay for SEC Climate Disclosure Rule

Amanda Lane Associate Editor Loyola University Chicago School of Law, JD 2025 The Securities and Exchange Commission (SEC) released its final Climate Disclosure Rule on March 6, 2024. As discussed in my last article, the proposed Climate Disclosure Rule would have required climate disclosures of publicly traded companies in three distinct categories. The first category, referred to …
Read more

HHS Makes Adjustments to SUD Part 2 Requirements

Posted on April 7, 2024Jacob TaylorCategories UncategorizedLeave a comment on HHS Makes Adjustments to SUD Part 2 Requirements

Aaron O’Neill Associate Editor Loyola University Chicago School of Law, JD 2024 On February 8, the Department of Health and Human Services (HHS) posted its new final rule to align 42 CFR Part 2 with HIPAA regulations, which will improve coordination of care for substance use disorder (SUD) patients and improve privacy protections. The new …
Read more

Right to Try Risks

Posted on April 7, 2024Jacob TaylorCategories UncategorizedLeave a comment on Right to Try Risks

Delaney Szwed   Associate Editor   Loyola University Chicago School of Law, JD 2024  When it comes to the regulation of a treatment option intended for individuals diagnosed with life threatening diseases, one may think that the Food and Drug Administration (FDA) is heavily involved. However, this is not the case under the Right to Try Act, which …
Read more

The Missing Oversight of Tesla and Elon Musk

Posted on April 7, 2024Jacob TaylorCategories UncategorizedLeave a comment on The Missing Oversight of Tesla and Elon Musk

Anokhi Manchanda Associate Editor Loyola University Chicago School of Law, JD 2025 Although Tesla is a power player in electric vehicles, there have recently been concerns after its $94 billion drop in market valuation at the beginning of 2024. For a company with a $750 billion valuation, that can be worrisome. However, there are bigger concerns when it comes …
Read more

Byte-Size Privacy Concerns: Navigating the Health Implications of Digital

Posted on April 7, 2024Jacob TaylorCategories UncategorizedLeave a comment on Byte-Size Privacy Concerns: Navigating the Health Implications of Digital

Kirsten Brueggemann Associate Editor Loyola University Chicago School of Law, JD 2025 The U.S. is tightening its regulation of online tracking technology, especially in relation to protected health information (PHI). The enforcement of the Health Insurance Portability and Accountability Act (HIPAA) falls under the jurisdiction of the Office of Civil Rights (OCR), which is part …
Read more

Is Meta the ultimate drug dealer?

Posted on April 7, 2024Jacob TaylorCategories UncategorizedLeave a comment on Is Meta the ultimate drug dealer?

Katherine O’Malley Associate Editor Loyola University Chicago School of Law, 2025 Only two countries in the world allow direct to consumers advertisements for pharmaceutical drugs: United States of America and New Zealand. The United States is currently facing a drug overdose epidemic, promoting both the FDA and DEA to intensify efforts to combat misleading  dangerous drug advertisements. …
Read more

Archives

Meta